Aries is a specialty pharmaceutical company focused on developing and commercializing best-in-class products in endoscopy and treating gastrointestinal diseases.
Our overarching mission is to help prevent and lower the risk for developing colon cancer.
Aries’ clinical pipeline is designed with the potential to improve patient outcomes in GI.
The Aries portfolio of products is licensed from Cosmo, a specialty pharmaceutical company headquartered in Dublin, Ireland. Cosmo’s products and clinical development pipeline seek to address unmet needs in the diagnosis and treatment of colon diseases, specifically focusing on innovative treatments for inflammatory bowel diseases (IBDs), colorectal cancer, and colon infections.
Cosmo’s proprietary MMX® technology is at the core of several of Aries’ pipeline products. MMX® technology is designed to deliver active ingredients in a targeted manner in the colon.
Learn more about the Aries pipeline.